Draft:Abhishesh Kumar Mehata

Dr. Abhishesh Kumar Mehata (born April 16, 1992) is a pharmaceutical engineer, scientist, inventor and researcher at the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, BHU. He is a former research scientist at the Sun pharmaceuticals research and development center. His area of research is to develop nanomedicine for the targeted therapy of breast cancer. He has more than 70 research publications in reputed international journals.

Mehata has received a master's degree in Pharmaceutics from the Indian Institute of Technology, BHU, under the supervision of Dr. M.S. Muthu. He is among the world's top 2% scientists, according to a list compiled by Stanford University. Mehata has been ranked among the top 100 university scientists. He is editor of Journal of Biomaterials, Cardiovascular therapeutics , review editor of nanomaterials (Frontiers in nanotechnology) and former student editor of Pharmstudent.

His recently developed targeted nanomedicine has demonstrated promising outcomes in preclinical studies for breast cancer therapy. He has also assisted the researcher in understanding immunological targeting for COVID-19 immunotherapy.